SHILPA MEDICARE LTD. - 530549 - Analysts / Investors' Call
Analysts/ Investors'' call05-07-2024
This pharma stock has surged 16% on Friday; zoomed over 100% so far in CY24
Shilpa Medicare hit a multi-year high of Rs 672.50, rallied 16% after the company's CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order.05-07-2024
Stock Of The Day: Shilpa Medicare Rallies After Order For Kidney Disease Treatment Key Levels
Here is all you need to know about the Shilpa Medicare's order win, its impact and future plans.05-07-2024
SHILPA MEDICARE LTD. - 530549 - Important Milestone For The CDMO Business Of Shilpa Medicare Limited ('SML')
Important milestone for the CDMO business of Shilpa Medicare Limited (SML) - Shilpa''s CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order04-07-2024
SHILPA MEDICARE LTD. - 530549 - Credit Rating - Shilpa Pharma Life Sciences Limited - Material Subsidiary Of Shilpa Medicare Limited , Holding Company
Credit Rating - Shilpa Pharma Life Sciences Limited - Material Subsidiary of Shilpa Medicare Limited, Holding Company03-07-2024
SHILPA MEDICARE LTD. - 530549 - USFDA Inspection Close-Out Of Bio-Analytical Laboratory, Unit 7, Shilpa Medicare Limited, Nacharam, Hyderabad, Telangana.
USFDA inspection close out of Bio-Analytical Laboratory, Unit 7, Shilpa Medicare Limited, Nacahram, Hyderabad25-06-2024
SHILPA MEDICARE LTD. - 530549 - Re-Designation Of Mr. Keshav Bhutada As Executive Director In Shilpa Pharma Lifesciences Ltd, A Material Subsidiary Of Shilpa Medicare Limited, On A Remuneration Of INR 1.00 Cr. (Rupees One Crore Only) Per Annum W.E.F 19 June, 2024 And Payment Of Remuneration Of INR 1.00 Cr. (Rupees One Crore Only) Per Annum W.E.F 1St April, 2024, To Mr. Madhav Bhutada, Managing Director, Shilpa Biocare Pvt. Limited, Wholly Owned Subsidiary Of Shilpa Medicare Limited, Subject To Members Approval In The Ensuing General Meeting
Re- designation of Mr. Keshav Bhutada as Executive Director in Shilpa Pharma Lifesciences Ltd, a material subsidiary of Shilpa Medicare Limited, on a remuneration of INR 1.00 Cr. (Rupees One Crore only) per annum w.ef 19 June, 2024 and payment of remuneration of INR 1.00 Cr. (Rupees One Crore only) per annum w.e.f. 1 April, 2024 to Mr. Madhav Bhutada , Managing Director, Shilpa Biocare Pvt. Ltd, a wholly owned subsidiary of Shilpa Medicare Limited, subject to members approval in the ensuing general meeting.19-06-2024